We are live on ! Find out more
ZYME icon

Zymeworks
ZYME

120 hedge funds and large institutions have $327M invested in Zymeworks in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 19 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 19

26% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 23

5% more funds holding

Funds holding: 114 → 120 (+6)

4% more call options, than puts

Call options by funds: $846K | Put options by funds: $816K

4.41% less ownership

Funds ownership: 90.95% → 86.54% (-4.4%)

53% less capital invested

Capital invested by funds: $694M → $327M (-$367M)

Holders
120
Holders Change
+6
Holders Change %
+5.26%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
52
Reduced
19
Closed
23
Calls
$846K
Puts
$816K
Net Calls
+$30K
Net Calls Change
-$48K

Top Buyers

1
AC
Armistice Capital
New York
+$40.2M
2
EAM
Eventide Asset Management
Massachusetts
+$22.8M
3
PA
Perceptive Advisors
New York
+$14.7M
4
RG
Redmile Group
California
+$11M
5
CCM
Camber Capital Management
Massachusetts
+$10.7M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$28.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$26.2M
3
Bank of America
Bank of America
North Carolina
-$23.7M
4
Goldman Sachs
Goldman Sachs
New York
-$17.8M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$15M
Name Holding Trade Value Shares
Change 		Change in
Stake
TIM
26
Timelo Investment Management
Ontario, Canada
$2.88M +$1.81M +203,442 +86%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.87M +$3.61M +405,408 +1,264%
Vanguard Group
28
Vanguard Group
Pennsylvania
$2.71M +$1.6M +179,461 +77%
UBS AM
29
UBS AM
Illinois
$2.2M -$661K -74,207 -18%
National Bank of Canada
30
National Bank of Canada
Quebec, Canada
$2.09M +$2.83M +317,955 +52,993%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.99M +$2.4M +269,300 +769%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$1.88M +$1.58M +177,647 +163%
VC
33
Vivo Capital
California
$1.87M – – –
Citadel Advisors
34
Citadel Advisors
Florida
$1.86M +$2.04M +229,379 +421%
Walleye Capital
35
Walleye Capital
New York
$1.81M +$2.46M +276,307 New
PIM
36
Platinum Investment Management
Australia
$1.54M – – –
SAM
37
Silvercrest Asset Management
New York
$1.46M +$18.6K +2,092 +0.9%
RJA
38
Raymond James & Associates
Florida
$1.11M -$525K -58,939 -26%
Norges Bank
39
Norges Bank
Norway
$1.1M – – –
CI Investments Inc
40
CI Investments Inc
Ontario, Canada
$1.04M +$697K +78,242 +97%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$980K +$314K +35,264 +31%
KCM
42
Kennedy Capital Management
Missouri
$936K -$509K -57,070 -29%
GCM
43
Graham Capital Management
Connecticut
$901K +$1.23M +137,601 New
State Street
44
State Street
Massachusetts
$899K +$107K +12,061 +10%
BC
45
Brookfield Corp
Ontario, Canada
$833K +$1.13M +127,130 New
Deutsche Bank
46
Deutsche Bank
Germany
$830K +$11.1K +1,241 +1%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$823K -$213K -23,925 -16%
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$808K +$1.1M +123,356 New
LCM
49
Laurion Capital Management
New York
$786K +$1.07M +120,000 New
PHP
50
Parkman Healthcare Partners
Connecticut
$781K +$692K +77,661 +187%
1
2
3 4 5

ZYME Hedge Fund Activity: Q1 2022 in Review

120 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q1 2022, worth a combined $327M — down 53% from $694M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ZYME positions and 23 closed out — a net gain of 6 holders — while 52 added to existing stakes and 19 trimmed.

The largest buyer was Armistice Capital, adding an estimated $40.2M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $28.1M sold.

  • 120 institutional investors held Zymeworks (ZYME) as of Q1 2022, up from 114 in Q4 2021.
  • Funds reported $327M of Zymeworks stock for Q1 2022, down 53% quarter-over-quarter.
  • 29 funds opened new Zymeworks positions in Q1 2022 and 23 closed out, a net change of +6 holders.
  • The largest Zymeworks buyer in Q1 2022 was Armistice Capital, an estimated $40.2M added.
  • The largest Zymeworks seller in Q1 2022 was T. Rowe Price Associates, an estimated $28.1M sold.

Based on aggregated 13F filings for Q1 2022.